Abstract
The discovery of new drugs usually is an expensive and long process, because it involves the development of new chemical bioactive compounds with desirable biological functions and minimal side effects. Considering insulin resistance and type 2 diabetes (DM2) as polymorphic metabolic and multifactorial disturbances, but unknown inflammatory origins, one could ask the effectiveness that he…